A smart flower-like polymeric micelle for pH-triggered anticancer drug release

被引:51
作者
Oh, Kyung Taek [2 ]
Oh, Young Taik [3 ]
Oh, Nam-Muk [1 ]
Kim, Kwangmyung [4 ]
Lee, Don Haeng [5 ]
Lee, Eun Seong [1 ]
机构
[1] Catholic Univ Korea, Div Biotechnol, Bucheon Si 420743, Gyeonggi Do, South Korea
[2] Chung Ang Univ, Coll Pharm, Seoul 155756, South Korea
[3] Yonsei Univ, Coll Med, Dept Diagnost Radiol, Seoul 120752, South Korea
[4] Korea Inst Sci & Technol, Biomed Res Ctr, Seoul 136791, South Korea
[5] Inha Univ, Dept Internal Med, Inchon 402751, Gyeonggi Do, South Korea
关键词
pH-sensitive flower-like micelle; 3-Diethylamino propyl; isothiocyanato-L-lysine; pH-dependent drug release; Tumor targeting; TUMOR EXTRACELLULAR PH; MACROMOLECULAR THERAPEUTICS; MULTIDRUG-RESISTANCE; CANCER; DELIVERY; NANOTECHNOLOGY; PERMEABILITY; DOXORUBICIN; GLYCOL); OPPORTUNITIES;
D O I
10.1016/j.ijpharm.2009.04.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Novel pH-responsive flower-like micelles were developed to provide the mechanism for pH-triggered drug release from drug carriers. The micelles (particle size: similar to 165 nm; critical micelle concentration (CMC): similar to 4 mu g/ml), constructed from poly(N-epsilon-(3-diethylamino)propyl isothiocyanatO-L-lysine)-b-poly(ethylene glycol)-b-poly(L-lactide) [poly(DEAP-Lys)-b-PEG-b-PLLA], were designed to have a self-assembled flower-like arrangement consisting of two hydrophobic blocks [deprotonated poly(DEAP-Lys) block and PLLA block] and a petal-like hydrophilic PEG block at physiological pH. As the pH decreases to slightly acidic pH (<pH 7.0), as in tumor extracellular pH (pH(e)), the flower-like micelles undergo a change in the hydrophobicity of the micellar core. The protonation of poly(DEAP-Lys) changed the physical property of the polymer from hydrophobic to hydrophilic, resulting in disintegration of the micellar core. The co-presence of a pH-insensitive PLLA block in the micellar core affected the protonation of poly(DEAP-Lys), allowing the micelle to be stable at pH 7.0-7.4. In this study using doxorubicin (DOX) as the model drug, DOX release from the micelles accelerated in response to tumor pH(e). (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:163 / 169
页数:7
相关论文
共 36 条
[31]   Improving the evaluation of new cancer treatments: challenges and opportunities [J].
Rothenberg, ML ;
Carbone, DR ;
Johnson, DH .
NATURE REVIEWS CANCER, 2003, 3 (04) :303-309
[32]   SMART drug delivery systems: Double-targeted pH-responsive pharmaceutical nanocarriers [J].
Sawant, R. M. ;
Hurley, J. P. ;
Salmaso, S. ;
Kale, A. ;
Tolcheva, E. ;
Levchenko, T. S. ;
Torchilin, V. P. .
BIOCONJUGATE CHEMISTRY, 2006, 17 (04) :943-949
[33]   Causes and consequences of tumour acidity and implications for treatment [J].
Stubbs, M ;
McSheehy, PMJ ;
Griffiths, JR ;
Bashford, CL .
MOLECULAR MEDICINE TODAY, 2000, 6 (01) :15-19
[34]  
TANNOCK IF, 1989, CANCER RES, V49, P4373
[35]   Synthesis and characterization of poly-L-lysine with controlled low molecular weight [J].
van Dijk-Wolthuis, WNE ;
van de Water, L ;
van de Wetering, P ;
van Steenbergen, MJ ;
Kettenes-van den Bosch, JJ ;
Schuyl, WJW ;
Hennink, WE .
MACROMOLECULAR CHEMISTRY AND PHYSICS, 1997, 198 (12) :3893-3906
[36]   An efficient vector for gene delivery:: α,β-poly(3-dimethylaminopropyl-D,L-aspartamide) [J].
Xue, Weihua ;
Diao, Huajia ;
Chen, Xi ;
Wang, Chunming ;
Chen, Jiangning ;
Zhang, Junfeng .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 66 (03) :327-333